Arrowpoint Advisory's Healthcare team has advised the shareholders of The GADA Group on a significant growth equity investment in the group by private equity investor RBS Equity Finance.
GADA is a leading medical devices and technology distributor and service provider, headquartered in the UK, with operations in Italy, Turkey and Romania. The group provides highly specialised, scalable, technically-led distribution and maintenance services to leading public and private sector hospitals as well as leading OEMs.
RBS' investment will support GADA in the acquisition of complementary businesses with a focus on Central and Eastern Europe, whilst also enabling GADA to further develop its broad range of products and services with which to support its hospital customers.
Richard Fetterman, Managing Director at Arrowpoint Advisory and Head of Healthcare in London commented: “This transaction demonstrates our ability to create and manage complex cross-border projects and to deliver to our clients ideal funding structures to support future growth.”
The GADA transaction is the fourth Healthcare sector deal completed by Arrowpoint Advisory in 2011 to date.